FDA Adverse Event Malfunction Summary report: N

BD PHASEAL OPTIMA INJECTOR (N35-O)

MDR report key: 12856745 · Received November 22, 2021

Report

Report Number
3003152976-2021-00773
Event Type
Malfunction
Date Received
November 22, 2021
Date of Event
October 25, 2021
Report Date
December 2, 2021
Manufacturer
BECTON DICKINSON, S.A.
Product Code
ONB
UDI-DI
00382905150524
PMA / PMN Number
K181221
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED AS A DEFAULT. CONCOMITANT MED PROD DATE: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED AS A DEFAULT.

Additional Manufacturer Narrative · 0

H6: INVESTIGATION SUMMARY: PHOTO RECEIVED FOR INVESTIGATION, UPON VISUAL INSPECTION SOME OPTIMA INJECTORS AND CONNECTORS ARE OBSERVED. HOWEVER; BASED ON PICTURES RECEIVED NO DAMAGES OR ISSUES COULD BE OBSERVED ON OPTIMA COMPONENTS THAT COULD BE RELATED TO THE EVENT REPORTED. A DEVICE HISTORY REVIEW WAS PERFORMED FOR REPORTED LOT 2107503 NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THIS ISSUE. A DEVICE HISTORY REVIEWED FROM LOT 1911102 (ASSEMBLY LOT 1911102) WAS REVIEWED AND IT IS NOTICED THAT THE EXPIRATION DATE WAS 31 OCTOBER 2020. THEREFORE; THE PRODUCT WAS EXPIRED AT THE MOMENT OF IT IS USE. SINCE THE SHELF LIFE WAS EXCEEDED, THE PROPER PRODUCT FUNCTIONALITY COULD NOT BE ENSURED. FIVE RETAINED SAMPLES FROM WERE EVALUATED. SINCE OPTIMA INJECTOR LOT PROVIDED 1911102 (MATERIAL REFERENCE 515052) WAS EXPIRED, RETAINED SAMPLES WERE NOT REQUESTED AS THE PROPER FUNCTIONALITY OF THE PRODUCT COULD NOT BE ENSURED. THEREFORE; FIVE RETAINED SAMPLES FROM OPTIMA INJECTOR LOT 2102316 WERE REQUESTED TO BE TESTED AGAINST OPTIMA RETAINED CONNECTORS FROM LOT 2107503. LUER LOCK MEASURED, NO DAMAGE OR DEFECTS OBSERVED, MEASUREMENTS MET ACCEPTANCE CRITERIA. PRODUCT UNDERGOES INSPECTIONS THROUGHOUT THE MANUFACTURING PROCESS TO ENSURE THE QUALITY AND FUNCTIONALITY OF THE DEVICE, INCLUDING VERIFICATION ALL CRITICAL DIMENSIONS ARE WITHIN SPECIFICATION AND THERE IS NO DAMAGE ON THE PRODUCT. TESTING RESULTS WERE REVIEWED FOR THE REPORTED LOT AND FOUND ALL PRODUCT MET REQUIRED SPECIFICATIONS. BASED ON THE QUALITY TEAM'S INVESTIGATION, WE ARE NOT ABLE TO IDENTIFY A ROOT CAUSE RELATED TO OUR MANUFACTURING PROCESS AT THIS TIME. IT SHOULD BE CONSIDERED THAT INJECTOR/CONNECTOR SEPARATION FAILURE MODE IS A DRY DISCONNECT WHICH PREVENTS LEAKAGE BY DESIGN. IT IS RECOMMENDED TO USE THE OPTIONAL M25-O CLAMP TO AVOID DRY DISCONNECTS DURING USE.

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED AS A DEFAULT. CONCOMITANT MED PROD DATE: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED AS A DEFAULT.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD INJECTOR N35-O HAD THE INJECTOR AND MATING COMPONENT SEPARATE.THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "PHASEAL OPTIMA INJECTOR AND CONNECTOR DISCONNECTED EASILY WHILE INFUSING ON A PATIENTG".

Description of Event or Problem · 0

IT WAS REPORTED THAT BD INJECTOR N35-O HAD THE INJECTOR AND MATING COMPONENT SEPARATE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "PHASEAL OPTIMA INJECTOR AND CONNECTOR DISCONNECTED EASILY WHILE INFUSING ON A PATIENT."

Description of Event or Problem · 0

IT WAS REPORTED THAT BD INJECTOR N35-O HAD THE INJECTOR AND MATING COMPONENT SEPARATE.THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "PHASEAL OPTIMA INJECTOR AND CONNECTOR DISCONNECTED EASILY WHILE INFUSING ON A PATIENTG".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1753833 BD PHASEAL OPTIMA INJECTOR (N35-O) INTRAVASCULAR ADMINISTRATION SET ONB BECTON DICKINSON, S.A. 2107503 00382905150524

Patients

Seq Age Sex Outcome Treatment
1 Unknown CONNECTOR C35-O